《美股》道指收升35點 標普500指數連跌三日 Circle再飆兩成
投資者考慮聯儲局未來減息路徑並關注中東最新局勢發展,美股周五高開後個別發展。道指輕微高收35點或近0.1%,報42,206點;納指終低收98點或0.5%,報19,447點。標普500指數低收13點或0.2%,報5,967點,連續第三個交易日下跌。
據報美國可能撤銷部分半導體製造商的豁免,晶片股領跌,英偉達(NVDA.US)收跌1.2%,台積電(TSM.US)跌1.9%。
大型科技股走個別,蘋果(AAPL.US)漲2.3%,特斯拉(TSLA.US)近平收,Meta(META.US)、亞馬遜(AMZN.US)跌逾1%。
穩定幣發行商Circle(CRCL.US)續有炒作,再飆升20.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.